Literature DB >> 11301110

Soluble Kit receptor blocks stem cell factor bioactivity in vitro.

D D Dahlen1, N L Lin, Y C Liu, V C Broudy.   

Abstract

Stem cell factor (SCF) is a growth factor that promotes the survival, proliferation, and differentiation of hematopoietic cells. SCF and its receptor, Kit, are normally present in both cell surface and soluble forms. Both forms of Kit can bind SCF. However, the function of soluble Kit is unknown. In order to determine if soluble Kit can modulate SCF activity, we produced a fusion protein, Kit-Fc, comprised of the extracellular domain of murine Kit and the Fc portion of human IgG(1) and investigated its ability to bind 125I-SCF and to inhibit SCF-stimulated hematopoietic colony growth in vitro. Stable cell lines expressing Kit-Fc were generated and Kit-Fc was purified to greater than 95% purity. Scatchard analysis demonstrated that Kit-Fc binds iodinated SCF with high affinity (Kd 570 pM). Kit-Fc also bound to transmembrane SCF displayed on the surface of fibroblasts. The murine mast cell line IC2 was engineered to express murine Kit on the cell surface and was demonstrated to proliferate in the presence of SCF. Kit-Fc completely blocked SCF-stimulated proliferation of IC2-Kit cells, but not IL-3-stimulated growth of IC2-Kit cells, demonstrating the specificity of Kit-Fc. We investigated the ability of Kit-Fc to block SCF-stimulated murine hematopoietic colony growth. Kit-Fc blocked SCF-stimulated erythroid colony growth as effectively as a neutralizing anti-Kit monoclonal antibody, ACK2, but did not block erythropoietin-stimulated erythroid colony growth. Likewise, Kit-Fc blocked SCF-stimulated myeloid colony growth as effectively as ACK2 antibody, but did not block IL-3- or GM-CSF-stimulated myeloid colony growth. These results indicate that a form of soluble Kit binds SCF with high affinity, and can specifically block the ability of SCF to stimulate hematopoietic colony growth, suggesting that one function of soluble Kit may be to modulate SCF bioactivity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11301110     DOI: 10.1016/s0145-2126(00)00122-3

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  10 in total

1.  Changes in biomarkers of inflammation and angiogenesis during androgen deprivation therapy for prostate cancer.

Authors:  Philip J Saylor; Kevin R Kozak; Matthew R Smith; Marek A Ancukiewicz; Jason A Efstathiou; Anthony L Zietman; Rakesh K Jain; Dan G Duda
Journal:  Oncologist       Date:  2012-02-02

2.  The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer.

Authors:  Henrique J Cardoso; Marília I Figueira; Sílvia Socorro
Journal:  J Cell Commun Signal       Date:  2017-06-27       Impact factor: 5.782

3.  A novel anti-c-Kit antibody-drug conjugate to treat wild-type and activating-mutant c-Kit-positive tumors.

Authors:  Jin-Ock Kim; Kwang-Hyeok Kim; Eun Ji Baek; Bomi Park; Min Kyung So; Byoung Joon Ko; Han-Jik Ko; Sang Gyu Park
Journal:  Mol Oncol       Date:  2021-08-29       Impact factor: 6.603

4.  A fully human anti-c-Kit monoclonal antibody 2G4 inhibits proliferation and degranulation of human mast cells.

Authors:  Kwang-Hyeok Kim; Jin-Ock Kim; Sang Gyu Park
Journal:  Mol Cell Biochem       Date:  2022-09-15       Impact factor: 3.842

5.  A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma.

Authors:  David S Hong; Michael S Gordon; Wolfram E Samlowski; Razelle Kurzrock; Nizar Tannir; David Friedland; David S Mendelson; Nicholas J Vogelzang; Erik Rasmussen; Benjamin M Wu; Michael B Bass; Zhandong D Zhong; Gregory Friberg; Leonard J Appleman
Journal:  Clin Genitourin Cancer       Date:  2013-11-13       Impact factor: 2.872

Review 6.  Advances in stem cell mobilization.

Authors:  Rusudan K Hopman; John F DiPersio
Journal:  Blood Rev       Date:  2014-01-14       Impact factor: 8.250

7.  The Roles of ADAMs Family Proteinases in Skin Diseases.

Authors:  Masakazu Kawaguchi; Vincent J Hearing
Journal:  Enzyme Res       Date:  2011-03-08

8.  Elevated Serum Tryptase and Endothelin in Patients with ST Segment Elevation Myocardial Infarction: Preliminary Report.

Authors:  Lukasz Lewicki; Janusz Siebert; Natalia Marek-Trzonkowska; Emilia Masiewicz; Tomasz Kolinski; Magdalena Reiwer-Gostomska; Radoslaw Targonski; Piotr Trzonkowski
Journal:  Mediators Inflamm       Date:  2015-05-18       Impact factor: 4.711

9.  Autocrine/Paracrine Loop Between SCF+/c-Kit+ Mast Cells Promotes Cutaneous Melanoma Progression.

Authors:  Tiziana Annese; Roberto Tamma; Mariella Bozza; Alfredo Zito; Domenico Ribatti
Journal:  Front Immunol       Date:  2022-01-24       Impact factor: 7.561

10.  Efficacy of SCF drug conjugate targeting c-KIT in gastrointestinal stromal tumor.

Authors:  Dengyang Zhang; Chunxiao He; Yao Guo; Jianfeng Li; Bo Li; Yuming Zhao; Liuting Yu; Zhiguang Chang; Hanzhong Pei; Ming Yang; Na Li; Qi Zhang; Yulong He; Yihang Pan; Zhizhuang Joe Zhao; Changhua Zhang; Yun Chen
Journal:  BMC Med       Date:  2022-08-24       Impact factor: 11.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.